Compare XBIT & NMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | NMG |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.4M | 473.9M |
| IPO Year | 2015 | 2015 |
| Metric | XBIT | NMG |
|---|---|---|
| Price | $2.30 | $1.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.75 |
| AVG Volume (30 Days) | 25.9K | ★ 749.8K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.09 | $1.37 |
| 52 Week High | $3.61 | $6.06 |
| Indicator | XBIT | NMG |
|---|---|---|
| Relative Strength Index (RSI) | 36.07 | 49.29 |
| Support Level | $2.26 | $1.39 |
| Resistance Level | $2.67 | $1.64 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 89.80 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The Company currently operates in two segments: the Mining projects (which includes the Matawinie Mine project and the Uatnan Mining Project) and the Battery Material Plant project.